Proteus Genomics is a highly-specialized, ground-breaking, genetic, infectious disease, microbiology laboratory. We are the undisputed leader in providing targeted, molecular diagnostics (PCR), focused on developing solutions to improve clinical and economic outcomes. Our distinct area of expertise is real-time quantitative reverse transcription polymerase chain reaction (RT qRT-PCR) and next generation DNA sequencing (NGS). Our high-complexity CLIA clinical reference scientists have developed an unparalleled suite of custom arrays. Proteus Genomics’ proprietary test panels include UTI, Wound, Nail, Respiratory, COVID, STI, and Women's Health. These novel, proprietary test offerings provide our partner physicians and providers the broadest, clearest, actionable patient results, as powered by our pioneering Pro-Vision software. Proteus Genomics is driven by a simple mission: precision-guided, patient-focused. Enabling us to deliver our providers and health systems enhanced, unrivaled treatment visibility.